Fesoterodine Fumarate
NDC 65162-370, Fesoterodine Fumarate, tablet, extended release, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-370
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205002
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-370 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FESOTERODINE FUMARATE8 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-370-03 | 65162037003 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-370-03) |
| 65162-370-09 | 65162037009 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-370-09) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1d3fdfcf-7406-4be0-90e9-b10c9257bf69
Use it
Look up 65162-370 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-370 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-370. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.